Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

LiGluR gene therapy reinstates visual responses in inherited blindness models

May 5, 2010

Antioxidant activity of dextromethorphan may be beneficial in retinitis pigmentosa

May 5, 2010

Preclinical data on nucleolin-binding peptide EP-302 support further development in cancer therapy

May 5, 2010

Cullin-1 emerges as a potential biomarker for the early diagnosis of human melanoma

May 5, 2010

Novel CRAC inhibitor synthesized at Incozen Therapeutics

May 5, 2010

AG-011 ineffective in phase II ulcerative colitis study

May 4, 2010

Clinical study, meta-analysis reveal intraocular pressure reductions with PF-4217329

May 4, 2010

Jak3 inhibitor R-348 prevents acute rejection and OAD in rodent model of transplantation

May 4, 2010

Endotis Pharma's synthetic oligosaccharide EP-80061 shows antitumor activity in animal models

May 4, 2010

GI-5005 plus pegIFNalpha-2a/RBV shows clinical potential in chronic HCV patients

May 4, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...